# FDA Inspection 965700 - Novacyl Wuxi Pharmaceutical Co., Ltd. - April 14, 2016

Source: https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/2229d702-8259-41c1-a77d-0cff43730a0f
Source feed: FDA_Inspections

> FDA Inspection 965700 for Novacyl Wuxi Pharmaceutical Co., Ltd. on April 14, 2016. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 965700
- Company Name: Novacyl Wuxi Pharmaceutical Co., Ltd.
- Inspection Date: 2016-04-14
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 853505 - 2013-10-18](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/c61ca5ce-1363-4c25-b082-421ccc50aa4c)
- [FDA Inspection 735469 - 2011-04-21](https://www.keypedia.com/records/fda_inspections/novacyl-wuxi-pharmaceutical-co-ltd/4e3494e6-555f-47b9-949a-0c56d74696af)

Company: https://www.keypedia.com/companies/novacyl-wuxi-pharmaceutical-co-ltd/df90cc11-f2af-4bb7-bf70-f32a8bcc4fb8

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c